Related Experiment Video
Updated: Jul 15, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Medication adherence in heart failure.
1Division of Cardiology, Saint Louis University School of Medicine, St. Louis, Missouri, USA. hauptmpj@slu.edu
Heart Failure Reviews
|May 5, 2007
Summary
Patient non-adherence to heart failure medication regimens is a major obstacle. Improving adherence through strategies like simplified dosing and better communication is crucial for real-world treatment success.
Area of Science:
- Cardiology
- Pharmacology
- Patient Adherence Research
Background:
- Non-adherence to medical regimens in heart failure (HF) is a significant clinical challenge.
- This non-adherence limits the translation of positive clinical trial outcomes to real-world patient care.
- Complex factors influence non-adherence, which is strongly linked to adverse patient outcomes.
Purpose of the Study:
- To review current and proposed strategies for improving medication adherence in heart failure patients.
- To highlight the impact of non-adherence on treatment effectiveness in a clinical setting.
Main Methods:
- Literature review of existing and proposed interventions for improving drug-taking behavior in heart failure.
- Analysis of approaches including in-hospital therapy initiation, simplified dosing regimens, and enhanced provider-patient communication.
Main Results:
- Non-adherence is a primary barrier to achieving optimal outcomes in heart failure management.
- Various strategies, including medication regimen simplification and improved communication, show potential for enhancing adherence.
Conclusions:
- Addressing non-adherence is critical for improving real-world heart failure treatment outcomes.
- Multifaceted approaches are needed to support patients in adhering to their medical regimens.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...